| Kristin Fassnacht, PT, DPT | |
|
201 S 4th St, Hiawatha, KS 66434-2402 | |
| (785) 742-7300 | |
| Not Available |
| Full Name | Kristin Fassnacht |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 15 Years |
| Location | 201 S 4th St, Hiawatha, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124411251 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 11-03988 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Amberwell Atchison Association | 2466363858 | 46 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.
Health professionals should push for a smoking ban in hospitals, research facilities, and health-care clinics as well as in public places, states a comment published online today by The Lancet to coincide with World No Tobacco Day.
According to a new study by researchers at the Massachusetts Institute of Technology's (MIT) School of Management and Analysis Group Inc., there is no evidence that the recent increase in prevalence of authorized generics has resulted in delays in generic entry into the marketplace.
PEPFAR will purchase up to 150 rapid tuberculosis (TB) Xpert testing devices and cartridges to test about 450,000 people for TB, "addressing a need to improve diagnoses of drug-resistant strains of disease, and to identify the disease in HIV-positive people in sub-Saharan Africa and Myanmar, the Office of the Global AIDS Coordinator announced" Tuesday, the Center for Global Health Policy's "Science Speaks" blog reports.
› Verified 2 days ago
| Provider Name | Amberwell Atchison Association |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1932151487 PECOS PAC ID: 2466363858 Enrollment ID: O20040329001560 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.
Health professionals should push for a smoking ban in hospitals, research facilities, and health-care clinics as well as in public places, states a comment published online today by The Lancet to coincide with World No Tobacco Day.
According to a new study by researchers at the Massachusetts Institute of Technology's (MIT) School of Management and Analysis Group Inc., there is no evidence that the recent increase in prevalence of authorized generics has resulted in delays in generic entry into the marketplace.
PEPFAR will purchase up to 150 rapid tuberculosis (TB) Xpert testing devices and cartridges to test about 450,000 people for TB, "addressing a need to improve diagnoses of drug-resistant strains of disease, and to identify the disease in HIV-positive people in sub-Saharan Africa and Myanmar, the Office of the Global AIDS Coordinator announced" Tuesday, the Center for Global Health Policy's "Science Speaks" blog reports.
› Verified 2 days ago
| Provider Name | Stars, Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1578637500 PECOS PAC ID: 9830129865 Enrollment ID: O20190531000927 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.
Health professionals should push for a smoking ban in hospitals, research facilities, and health-care clinics as well as in public places, states a comment published online today by The Lancet to coincide with World No Tobacco Day.
According to a new study by researchers at the Massachusetts Institute of Technology's (MIT) School of Management and Analysis Group Inc., there is no evidence that the recent increase in prevalence of authorized generics has resulted in delays in generic entry into the marketplace.
PEPFAR will purchase up to 150 rapid tuberculosis (TB) Xpert testing devices and cartridges to test about 450,000 people for TB, "addressing a need to improve diagnoses of drug-resistant strains of disease, and to identify the disease in HIV-positive people in sub-Saharan Africa and Myanmar, the Office of the Global AIDS Coordinator announced" Tuesday, the Center for Global Health Policy's "Science Speaks" blog reports.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristin Fassnacht, PT, DPT 201 S 4th St, Hiawatha, KS 66434-2402 Ph: () - | Kristin Fassnacht, PT, DPT 201 S 4th St, Hiawatha, KS 66434-2402 Ph: (785) 742-7300 |
News Archive
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, announces the final data from the ENTRANCE Phase IIa trial in inflammatory bowel disease with vidofludimus, an oral inhibitor of interleukin-17 release and DHODH, including the secondary endpoints comprising the analysis of CDAI and CAI disease scores, change of prednisolone intake and threshold doses, safety, pharmacokinetics and biomarkers.
Health professionals should push for a smoking ban in hospitals, research facilities, and health-care clinics as well as in public places, states a comment published online today by The Lancet to coincide with World No Tobacco Day.
According to a new study by researchers at the Massachusetts Institute of Technology's (MIT) School of Management and Analysis Group Inc., there is no evidence that the recent increase in prevalence of authorized generics has resulted in delays in generic entry into the marketplace.
PEPFAR will purchase up to 150 rapid tuberculosis (TB) Xpert testing devices and cartridges to test about 450,000 people for TB, "addressing a need to improve diagnoses of drug-resistant strains of disease, and to identify the disease in HIV-positive people in sub-Saharan Africa and Myanmar, the Office of the Global AIDS Coordinator announced" Tuesday, the Center for Global Health Policy's "Science Speaks" blog reports.
› Verified 2 days ago
Brandon W Deeds, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 700 Oregon St, Hiawatha, KS 66434 Phone: 785-742-7606 Fax: 785-742-4490 | |
David John Nachtigal, PT/RCP Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 Oregon St, Hiawatha, KS 66434 Phone: 785-742-7606 Fax: 785-742-4490 | |
Mr. John Michael Sheeran Jr., PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 S 4th St, Hiawatha, KS 66434 Phone: 785-742-7300 | |
Mrs. Teresa Marie Miller, PHYSICAL THEREPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 700 Oregon St, Hiawatha, KS 66434 Phone: 785-742-7606 Fax: 785-742-4490 | |
Rehabvisions Physical Therapist Medicare: Medicare Enrolled Practice Location: 819 Oregon St, Hiawatha, KS 66434 Phone: 785-742-2201 Fax: 785-742-2202 | |
Carmen Rottinghaus, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 700 Oregon St, Hiawatha, KS 66434 Phone: 785-742-7606 Fax: 785-742-4490 |